Ethyol Paragraph IV Certification
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for MedImmune's Ethyol (amifostine) was submitted April 16, FDA's updated list of Paragraph IV filings indicates.